✦ LIBER ✦

6609 POSTER Vandetanib in advanced non-small-cell lung cancer: an ongoing clinical evaluation programme

✍ Scribed by Groen, H.J.M.; Baas, P.; Kennedy, S.J.; Langmuir, P.

Book ID: 123151749
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 79 KB
Volume: 5
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(07)71437-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Clinical Development of Vandetanib:

The Clinical Development of Vandetanib: Updates on Ongoing Phase III Clinical Trials in Advanced Non—Small-Cell Lung Cancer

✍ John Heymach 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 70 KB

Phase III Trial of Vandetanib Compared W

Phase III Trial of Vandetanib Compared With Erlotinib in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer

✍ Natale, R. B.; Thongprasert, S.; Greco, F. A.; Thomas, M.; Tsai, C.-M.; Sunpawer 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 298 KB

Phase II study of docetaxel (TXT) and ca

Phase II study of docetaxel (TXT) and carboplatin (CBDCA) combination in advanced non-small cell lung cancer (NSCLC). An ongoing study

✍ Giannakakis, T; Kakolyris, S; Papadouris, S; Theodoropoulos, I; Kalbakis, K; And 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Vandetanib Versus Gefitinib in Patients

Vandetanib Versus Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer: Results From a Two-Part, Double-Blind, Randomized Phase II Study

✍ Natale, R. B.; Bodkin, D.; Govindan, R.; Sleckman, B. G.; Rizvi, N. A.; Capo, A. 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 210 KB

P-333 An economic evaluation of differen

P-333 An economic evaluation of different chemotherapy regimensused in the treatment of advanced non-small cell lung cancer

✍ Massuti, B.; Burgos, A.; Martí Ciriquián, J.; Llinares, F.; Montoyo, R.; Pena, E 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 135 KB

1443 POSTER High Blood Neutrophil-to-lym

1443 POSTER High Blood Neutrophil-to-lymphocyte Ratio as an Indicator of Poor Prognosis in Advanced Non Small Cell Lung Cancer

✍ D. Torrejon Castro; S. Cedres; G. Argiles; I. Nunez; V. Rodriguez-Freixinos; N. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB